[HLFG] QoQ Quarter Result on 31-Mar-2015 [#3]

Stock
[HLFG] HONG LEONG FINANCIAL GROUP BHD
Announcement Date
26-May-2015
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2015
Quarter
31-Mar-2015 [#3]
Profit Trend
QoQ- -14.24%
YoY- -12.34%
Quarter Report
Latest QR
Upcoming QR
HLFG's Result
HLFG's Financial Summary
View:
Show?
Quarter Result
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Revenue 1,165,030 1,146,622 1,218,926 1,045,958 1,142,551 1,083,509 1,156,615 0.48%
PBT 487,356 696,979 780,454 699,716 796,122 746,993 715,611 -22.53%
Tax -90,951 -115,300 -90,791 -150,566 -166,432 -155,119 -55,893 38.22%
NP 396,405 581,679 689,663 549,150 629,690 591,874 659,718 -28.72%
-
NP to SH 263,449 386,882 441,250 363,499 423,839 392,155 450,255 -29.97%
-
Tax Rate 18.66% 16.54% 11.63% 21.52% 20.91% 20.77% 7.81% -
Total Cost 768,625 564,943 529,263 496,808 512,861 491,635 496,897 33.64%
-
Net Worth 14,074,607 13,787,257 13,111,428 12,528,668 12,087,260 11,806,591 11,465,795 14.60%
Dividend
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Div - 136,299 - 261,886 - 136,310 - -
Div Payout % - 35.23% - 72.05% - 34.76% - -
Equity
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Net Worth 14,074,607 13,787,257 13,111,428 12,528,668 12,087,260 11,806,591 11,465,795 14.60%
NOSH 1,147,516 1,048,460 1,050,595 1,047,547 1,046,516 1,048,542 1,047,104 6.27%
Ratio Analysis
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
NP Margin 34.03% 50.73% 56.58% 52.50% 55.11% 54.63% 57.04% -
ROE 1.87% 2.81% 3.37% 2.90% 3.51% 3.32% 3.93% -
Per Share
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 108.02 109.36 116.02 99.85 109.18 103.33 110.46 -1.47%
EPS 24.50 36.90 42.00 34.70 40.50 37.40 43.00 -31.20%
DPS 0.00 13.00 0.00 25.00 0.00 13.00 0.00 -
NAPS 13.05 13.15 12.48 11.96 11.55 11.26 10.95 12.37%
Adjusted Per Share Value based on latest NOSH - 1,047,547
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 102.67 101.04 107.42 92.17 100.69 95.48 101.93 0.48%
EPS 23.22 34.09 38.88 32.03 37.35 34.56 39.68 -29.96%
DPS 0.00 12.01 0.00 23.08 0.00 12.01 0.00 -
NAPS 12.4031 12.1498 11.5543 11.0407 10.6517 10.4044 10.1041 14.60%
Price Multiplier on Financial Quarter End Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 -
Price 13.96 14.00 15.16 16.96 16.52 17.60 16.14 -
P/RPS 12.92 12.80 13.07 16.99 15.13 17.03 14.61 -7.84%
P/EPS 57.15 37.94 36.10 48.88 40.79 47.06 37.53 32.25%
EY 1.75 2.64 2.77 2.05 2.45 2.13 2.66 -24.29%
DY 0.00 0.93 0.00 1.47 0.00 0.74 0.00 -
P/NAPS 1.07 1.06 1.21 1.42 1.43 1.56 1.47 -19.03%
Price Multiplier on Announcement Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 23/02/16 17/11/15 26/08/15 26/05/15 25/02/15 25/11/14 26/08/14 -
Price 14.14 13.70 13.22 15.80 16.76 18.12 17.04 -
P/RPS 13.09 12.53 11.39 15.82 15.35 17.54 15.43 -10.35%
P/EPS 57.89 37.13 31.48 45.53 41.38 48.45 39.63 28.65%
EY 1.73 2.69 3.18 2.20 2.42 2.06 2.52 -22.12%
DY 0.00 0.95 0.00 1.58 0.00 0.72 0.00 -
P/NAPS 1.08 1.04 1.06 1.32 1.45 1.61 1.56 -21.68%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment